{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:35:55Z","timestamp":1793165755095,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xphs.2026.104559","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:55:10Z","timestamp":1792684510000},"page":"104559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polymer nanoparticle-mediated delivery of microRNA 145: A potential therapeutic strategy for hepatocellular carcinoma in an experimental model"],"prefix":"10.1016","volume":"115","author":[{"given":"Lamyaa","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"ElAhwany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elzallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Aboushousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hatem Hamdy","family":"Odah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"AbouTaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Zoheiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Mohandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"AbdelAlim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Mostafa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2026.104559_bib0001","doi-asserted-by":"crossref","first-page":"879","DOI":"10.21608\/jbaar.2024.393371","article-title":"Hepatocellular carcinoma (HCC) in Egypt: prevalence, risk factors, diagnosis and prevention: a review","volume":"10","author":"Yameny","year":"2024","journal-title":"J Biosci Appl Res"},{"issue":"6","key":"10.1016\/j.xphs.2026.104559_bib0002","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/medicina59061115","article-title":"Angiogenesis and hepatocellular carcinoma: from molecular mechanisms to systemic therapies","volume":"59","author":"Pinto","year":"2023","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.xphs.2026.104559_bib0003","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bbrc.2014.03.107","article-title":"MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling","volume":"446","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.xphs.2026.104559_bib0004","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"10.1016\/j.xphs.2026.104559_bib0005","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.3390\/cancers16234059","article-title":"Current treatment methods in hepatocellular carcinoma","volume":"16","author":"Krupa","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0006","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-51340-1","article-title":"Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy","volume":"16","author":"Elkramani","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41420-023-01718-1","article-title":"microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance","volume":"9","author":"Fattahi","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.xphs.2026.104559_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8029721","article-title":"Development of MicroRNAs as potential therapeutics against cancer","author":"Abd-Aziz","year":"2020","journal-title":"J Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41420-024-02200-2","article-title":"Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons","volume":"10","author":"Goyal","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.xphs.2026.104559_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1285370","article-title":"Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0012","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1038\/s41598-024-54795-2","article-title":"Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms","volume":"14","author":"Sayed","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.xphs.2026.104559_bib0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/pharmaceutics12040298","article-title":"Polymeric nanocarriers of drug delivery systems in cancer therapy","volume":"12","author":"Avramovi\u0107","year":"2020","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.xphs.2026.104559_bib0014","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.3390\/jcm12216867","article-title":"Advances of nanotechnology in the diagnosis and treatment of hepatocellular carcinoma","volume":"12","author":"Escutia-Guti\u00e9rrez","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.xphs.2026.104559_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pharmaceutics14020243","article-title":"MicroRNA-539-5p-loaded PLGA nanoparticles grafted with iRGD as a targeting treatment for choroidal neovascularization","volume":"14","author":"Alanazi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104559_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.105873","article-title":"Bioactive Moringa oleifera and Nigella sativa oils microcapsules alleviate high-fat-diet induced hepatic oxidative damage and inflammation in rats","volume":"64","author":"Mohammed","year":"2025","journal-title":"Food Biosci"},{"key":"10.1016\/j.xphs.2026.104559_bib0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.biopha.2017.08.099","article-title":"The biochemical effects of nano tamoxifen and some bioactive components in experimental breast cancer","volume":"95","author":"Ezzat","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.xphs.2026.104559_bib0018","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.xphs.2026.104559_bib0019","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/01913123.2020.1744783","article-title":"MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model","volume":"44","author":"El-Ahwany","year":"2020","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.xphs.2026.104559_bib0020","first-page":"1","article-title":"Investigating the hepatoprotective effects of Onopordum cyrenaicum: phytochemical, biological, and computational approaches to combat liver damage","author":"Elshibani","year":"2025","journal-title":"Nat Prod Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104559_bib0021","first-page":"517","article-title":"Red beet Peel-loaded Liposome's impact on metabolic syndrome rats and its use as fortifier in yoghurt powder","volume":"66","author":"Alshafei","year":"2023","journal-title":"Egypt J Chem"},{"key":"10.1016\/j.xphs.2026.104559_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2024.104286","article-title":"Moringa oleifera L. mediated zinc oxide nano-biofertilizer alleviates non-alcoholic steatohepatitis via modulating de novo lipogenesis pathway and miRNA-122 expression","volume":"60","author":"Mohammed","year":"2024","journal-title":"Food Biosci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104559_bib0023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2- \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.xphs.2026.104559_bib0024","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/jcp.36.5.609-d","article-title":"Theory and practice of histological techniques","volume":"36","author":"Drury","year":"1983","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.xphs.2026.104559_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2026.108604","article-title":"Harnessing the River Red Gum: a promising nano-delivery for optimal therapeutic effect against HFD-induced non-alcoholic steatohepatitis (NASH) in rats","author":"Mohammed","year":"2026","journal-title":"Food Biosci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104559_bib0026","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s10973-024-13873-3","article-title":"Performance evaluation of various training functions using ANN to predict the thermal conductivity of EG\/water-based GNP\/CNC hybrid nanofluid for heat transfer application","volume":"150","author":"Hasan","year":"2025","journal-title":"J Therm Anal Calorim"},{"issue":"4","key":"10.1016\/j.xphs.2026.104559_bib0027","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4103\/ejim.ejim_73_19","article-title":"Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy","volume":"31","author":"Elrabat","year":"2019","journal-title":"Egypt J Intern Med"},{"key":"10.1016\/j.xphs.2026.104559_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1363695","article-title":"The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma","volume":"14","author":"Lu","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104559_bib0029","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.livres.2018.06.002","article-title":"Roles of microRNA in liver cancer","volume":"2","author":"Tao","year":"2018","journal-title":"Liver Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1158\/0008-5472.CAN-09-2021","article-title":"MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1","volume":"70","author":"Sachdeva","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2026.104559_bib0031","article-title":"Loss of TARBP2 drives the progression of hepatocellular carcinoma via miR-145-SERPINE1 axis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2026.104559_bib0032","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2147\/CMAR.S300678","article-title":"microRNA-145-5p inhibits migration, invasion, and metastasis in hepatocellular carcinoma by inhibiting ARF6","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10.1016\/j.xphs.2026.104559_bib0033","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3892\/or.2014.3424","article-title":"MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.xphs.2026.104559_bib0034","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.2147\/OTT.S245346","article-title":"miR-145 inhibits Th9 cell differentiation by suppressing activation of the PI3K\/Akt\/mTOR\/p70S6K\/HIF-1\u03b1 pathway in malignant ascites from liver cancer","author":"Huang","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13046-024-03167-9","article-title":"Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma","volume":"43","author":"Rong","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.xphs.2026.104559_bib0036","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/hepr.12152","article-title":"miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17","volume":"44","author":"Yang","year":"2014","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104559_bib0037","article-title":"Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis","volume":"57","author":"Wang","year":"2025","journal-title":"Ann Med"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926004077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926004077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:16:20Z","timestamp":1793164580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926004077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0022354926004077"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104559","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer nanoparticle-mediated delivery of microRNA 145: A potential therapeutic strategy for hepatocellular carcinoma in an experimental model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104559"}}